Page 300 - Read Online

Page 14 of 16 Thirugnanam et al. Vessel Plus 2020;4:26 I http://dx.doi.org/10.20517/2574-1209.2020.18

deficiency induced insulin resistance in adipose tissue. Mol Metab 2019;28:26-35.
18. Li J, Feng B, Nie Y, Jiao P, Lin X, et al. Sucrose nonfermenting-related kinase regulates both adipose inflammation and energy
homeostasis in mice and humans. Diabetes 2018;67:400-11.
19. Li Y, Nie Y, Helou Y, Ding G, Feng B, et al. Identification of sucrose non-fermenting-related kinase (SNRK) as a suppressor of adipocyte
inflammation. Diabetes 2013;62:2396-409.
20. Pramanik K, Chun CZ, Garnaas MK, Samant GV, Li K, et al. Dusp-5 and Snrk-1 coordinately function during vascular development and
disease. Blood 2009;113:1184-91.
21. Lu Q, Xie Z, Yan C, Ding Y, Ma Z, et al. SNRK (sucrose nonfermenting 1-related kinase) promotes angiogenesis in vivo. Arterioscler
Thromb Vasc Biol 2018;38:373-85.
22. Lu Q, Ma Z, Ding Y, Bedarida T, Chen L, et al. Circulating miR-103a-3p contributes to angiotensin II-induced renal inflammation and
fibrosis via a SNRK/NF-κB/p65 regulatory axis. Nat Commun 2019;10:2145.
23. Hopp EE, Cossette SM, Kumar SN, Eastwood D, Ramchandran R, et al. Sucrose non-fermenting related kinase expression in ovarian
cancer and correlation with clinical features. Cancer Invest 2017;35:456-62.
24. Yoshida K, Yamada M, Nishio C, Konishi A, Hatanaka H. SNRK, a member of the SNF1 family, is related to low K[+]-induced apoptosis
of cultured rat cerebellar granule neurons. Brain Res 2000;873:274-82.
25. Manning G, Whyte DB, Martinez R, Hunter T, Sudarsanam S. The protein kinase complement of the human genome. Science
2002;298:1912-34.
26. Bright NJ, Thornton C, Carling D. The regulation and function of mammalian AMPK-related kinases. Acta Physiol (Oxf) 2009;196:15-26.
27. Rider MH. The ubiquitin-associated domain of AMPK-related protein kinases allows LKB1-induced phosphorylation and activation.
Biochem J 2006;394:e7-9.
28. Chen L, Jiao ZH, Zheng LS, Zhang YY, Xie ST, et al. Structural insight into the autoinhibition mechanism of AMP-activated protein
kinase. Nature 2009;459:1146-9.
29. Shaw RJ, Kosmatka M, Bardeesy N, Hurley RL, Witters LA, et al. The tumor suppressor LKB1 kinase directly activates AMP-activated
kinase and regulates apoptosis in response to energy stress. Proc Natl Acad Sci U S A 2004;101:3329-35.
30. Alessi DR, Sakamoto K, Bayascas JR. LKB1-dependent signaling pathways. Annu Rev Biochem 2006;75:137-63.
31. Sapkota GP, Boudeau J, Deak M, Kieloch A, Morrice N, et al. Identification and characterization of four novel phosphorylation sites (Ser31,
Ser325, Thr336 and Thr366) on LKB1/STK11, the protein kinase mutated in Peutz-Jeghers cancer syndrome. Biochem J 2002;362:481-90.
32. Sapkota GP, Kieloch A, Lizcano JM, Lain S, Arthur JS, et al. Phosphorylation of the protein kinase mutated in Peutz-Jeghers cancer
syndrome, LKB1/STK11, at Ser431 by p90(RSK) and cAMP-dependent protein kinase, but not its farnesylation at Cys(433), is essential
for LKB1 to suppress cell vrowth. J Biol Chem 2001;276:19469-82.
33. Hemminki A, Markie D, Tomlinson I, Avizienyte E, Roth S, et al. A serine/threonine kinase gene defective in Peutz-Jeghers syndrome.
Nature 1998;391:184-7.
34. Baas AF, Boudeau J, Sapkota GP, Smit L, Medema R, et al. Activation of the tumour suppressor kinase LKB1 by the STE20-like
pseudokinase STRAD. EMBO J 2003;22:3062-72.
35. Boudeau J, Baas AF, Deak M, Morrice NA, Kieloch A, et al. MO25alpha/beta interact with STRADalpha/beta enhancing their ability to
bind, activate and localize LKB1 in the cytoplasm. EMBO J 2003;22:5102-14.
36. Xie Z, Dong Y, Zhang J, Scholz R, Neumann D, et al. Identification of the serine 307 of LKB1 as a novel phosphorylation site essential
for its nucleocytoplasmic transport and endothelial cell angiogenesis. Mol Cell Biol 2009;29:3582-96.
37. Boudeau J, Scott JW, Resta N, Deak M, Kieloch A, et al. Analysis of the LKB1-STRAD-MO25 complex. J Cell Sci 2004;117:6365-75.
38. Nakano H, Minami I, Braas D, Pappoe H, Wu X, et al. Glucose inhibits cardiac muscle maturation through nucleotide biosynthesis. Elife
2017;6:e29330.
39. Bartelds B, Knoester H, Smid GB, Takens J, Visser GH, et al. Perinatal changes in myocardial metabolism in lambs. Circulation
2000;102:926-31.
40. Fisher DJ, Heymann MA, Rudolph AM. Myocardial oxygen and carbohydrate consumption in fetal lambs in utero and in adult sheep. Am
J Physiol 1980;238:H399-405.
41. Warshaw JB, Terry ML. Cellular energy metabolism during fetal development. II. Fatty acid oxidation by the developing heart. J Cell
Biol 1970;44:354-60.
42. Werner JC, Sicard RE, Schuler HG. Palmitate oxidation by isolated working fetal and newborn pig hearts. Am J Physiol
1989;256:E315-21.
43. Piquereau J, Ventura-Clapier R. Maturation of Cardiac Energy Metabolism During Perinatal Development. Front Physiol 2018;9:959.
44. Kolwicz SC Jr, Purohit S, Tian R. Cardiac metabolism and its interactions with contraction, growth, and survival of cardiomyocytes. Circ
Res 2013;113:603-16.
45. Wisneski JA, Gertz EW, Neese RA, Gruenke LD, Craig JC. Dual carbon-labeled isotope experiments using D-(6-14C) glucose
and L-(1,2,3-13C3) lactate: a new approach for investigating human myocardial metabolism during ischemia. J Am Coll Cardiol
1985;5:1138-46.
46. Gertz EW, Wisneski JA, Stanley WC, Neese RA. Myocardial substrate utilization during exercise in humans. Dual carbon-labeled
carbohydrate isotope experiments. J Clin Invest 1988;82:2017-25.
47. D’Souza K, Nzirorera C, Kienesberger PC. Lipid metabolism and signaling in cardiac lipotoxicity. Biochim Biophys Acta
2016;1861:1513-24.
48. Loirand G, Guérin P, Pacaud P. Rho kinases in cardiovascular physiology and pathophysiology. Circ Res 2006;98:322-34.